ArticleCell communication and signaling : CCS2024

KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.

Rafael Rosell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.